若您需要咨询产品或有任何技术问题,请通过官方电话 400 885 9050 或邮箱 info.cn@stemcell.com 与我们联系

ImmunoCult™ 人CD3/CD28 T细胞激活剂

cGMP,人T细胞激活扩增试剂

产品号 #(选择产品)

产品号 #100-0784_C

cGMP,人T细胞激活扩增试剂

产品优势

  • 在相关cGMP条件下生产的激活剂,激活的T细胞可用于临床应用
  • 无需使用磁珠、饲养细胞或抗原即可实现稳定激活效果
  • 通过温和的激活刺激,维持激活和扩增后的T细胞的高活性
  • 高度稳定,过滤灭菌的可溶性试剂

总览

实现人T细胞的稳定激活和扩增,用于临床应用—无需使用磁珠,饲养细胞或抗原。
本品温和的激活刺激方式保证了活化T细胞的高活性,可以搭配ImmunoCult™- XF培养基实现更优越的扩增效果,该培养基是一种根据相关cGMP法规生产的高性能T细胞扩增培养基。ImmunoCult™人CD3/CD28 T细胞激活剂由可溶性抗体复合物组成,可与细胞表面配体CD3和CD28结合并交联,从而为T细胞激活和培养提供所需的初级和共刺激信号。
ImmunoCult™人CD3/CD28 T细胞激活剂是专为细胞治疗临床研究应用而设计的,符合USP<1043> 和/或PH. EUR.5.2.12.中规定的框架,可作为辅助材料(AM)使用。STEMCELL可与您合作,根据已获批的临床试验新药(IND)申请,生物制品许可申请(BLA)或临床试验申请(CTA),将该试剂认证为辅助材料。点击此处,了解更多关于我们如何支持您的法规需求的信息。

包含
• Anti-human CD3 monospecific antibody complex • Anti-human CD28 monospecific antibody complex • Phosphate buffered-saline (PBS),containing 0.02% TWEEN® 20
 
亚型
添加剂
 
细胞类型
T 细胞,T 细胞,CD4+,T 细胞,CD8+
 
种属

 
应用
激活,细胞培养,扩增
 
品牌
ImmunoCult
 
研究领域
癌症,免疫,细胞治疗开发
 

实验数据

Activated human T cells clustering together.

Figure 1. Morphology of Activated Human T Cells Stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator

A clustered morphology is seen in activated human T cells. Cells were isolated using EasySep™ Human T Cell Isolation Kit, stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator for 3 days in ImmunoCult™-XF supplemented with recombinant human interleukin-2 (rhIL-2).

Flow cytometry data showing human T cell activation assessed by CD25 expression.

Figure 2. Activation of Human T Cells Stimulated with ImmunoCult™ Human CD3/CD28 Activator.

Human T cells were stimulated with ImmunoCult™ Human CD3/CD28 T Cell Activator and cultured in ImmunoCult™-XF . Activation of viable CD4+ and CD8+ T cells were assessed by CD25 expression, using flow cytometry. Following 3 days of culture, the frequency of CD25-positive cells was (A) 75.5% for CD4+ T cells and (B) 65.3% for CD8+ T cells . The gray line depicts day 3 CD4+ and CD8+ T cells cultured without ImmunoCult™ Human CD3/CD28 T Cell Activator.

Human T cell cumulative fold expansion and activation during a 12-day culture period.

Figure 3. Robust Human T Cell Expansion and High Viability Achieved Using ImmunoCult™ Human CD3/CD28 T Cell Activator

Human T cells were expanded over 12 days with ImmunoCult™ Human CD3/CD28 T Cell Activator in ImmunoCult™-XF supplemented with rhIL-2. On day 0, 1 x 10^6 isolated human T cells were stimulated with 25 μL of ImmunoCult™ Human CD3/CD28 T Cell Activator in ImmunoCult™-XF supplemented rhIL-2. No additional ImmunoCult™ Human CD3/CD28 T Cell Activator was added during the 12-day culture period (mean ± SD in 3 experiments with 7 donors).

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明,或浏览下方更多实验方案。

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0784
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-0784
Lot #
All
Language
English

应用领域

本产品专为以下研究领域设计,适用于工作流程中的高亮阶段。探索这些工作流程,了解更多我们为各研究领域提供的其他配套产品。

相关材料与文献

技术资料 (11)

文献 (2)

Th17 cell-derived miR-155-5p modulates interleukin-17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis. L. Han et al. Journal of clinical laboratory analysis 2022 jun

Abstract

BACKGROUND miR-155-5p is associated with autoimmune diseases. T helper 17 (Th17) cells, interleukin (IL)-17, and suppressor of cytokines signaling 1 (SOCS1) have important roles in the pathogenesis of systemic sclerosis (SSc). The purpose of this study was to explore the role of miR-155-5p in the regulation of IL-17 and SOCS1 expression in Th17 cells and the subsequent effect on SSc disease progression. METHODS Th17 cells were isolated from peripheral blood mononuclear cells of SSc patients and healthy controls (HCs). RT-qPCR and western blotting were used to examine the expression patterns of miR-155-5p, IL-17, and SOCS1. Luciferase reporter assays were performed to confirm SOCS1 as a target of miR-155-5p. RNA pull-down assays were performed to detect the interaction of IL-17 and SOCS1 with miR-155-5p. In situ hybridization was performed to analyze the co-expression pattern of miR-155-5p and IL17A in Th17 cells. RESULTS The levels of Th17 cell-derived miR-155-5p were significantly up-regulated in SSc patients compared with HCs, and its levels were negatively correlated with SOCS1 levels. Meanwhile, miR-155-5p positively regulated IL-17 expression levels in Th17 cells isolated from SSc patients as the disease progressed. Using pmirGLO vectors, SOCS1 was confirmed as a target of miR-155-5p. The binding status of IL-17 and SOCS1 to miR-155-5p was related to SSc progression. An increase in the co-localization of miR-155-5p and IL-17 was associated with greater SSc progression. CONCLUSIONS IL-17 and SOCS1 expression modulated by Th17 cell-derived miR-155-5p are critical for SSc progression, which may provide novel insights into the pathogenesis of SSc.
Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1. C. M. Capelle et al. Immunology 2022 apr

Abstract

Stress hormones are believed to skew the CD4 T-cell differentiation towards a Th2 response via a T-cell-extrinsic mechanism. Using isolated primary human na{\{i}}ve and memory CD4 T cells here we show that both adrenergic- and glucocorticoid-mediated stress signalling pathways play a CD4 na{\"{i}}ve T-cell-intrinsic role in regulating the Th1/Th2 differentiation balance. Both stress hormones reduced the Th1 programme and cytokine production by inhibiting mTORC1 signalling via two parallel mechanisms. Stress hormone signalling inhibited mTORC1 in na{\"{i}}ve CD4 T cells (1) by affecting the PI3K/AKT pathway and (2) by regulating the expression of the circadian rhythm gene period circadian regulator 1 (PER1). Both stress hormones induced the expression of PER1 which inhibited mTORC1 signalling thus reducing Th1 differentiation. This previously unrecognized cell-autonomous mechanism connects stress hormone signalling with CD4 T-cell differentiation via mTORC1 and a specific circadian clock gene namely PER1."

更多信息

更多信息
种属 Human
Contains • Anti-human CD3 monospecific antibody complex • Anti-human CD28 monospecific antibody complex • Phosphate buffered-saline (PBS), containing 0.02% TWEEN® 20
THIS PRODUCT IS MANUFACTURED AND TESTED FOLLOWING RELEVANT CGMPs UNDER A CERTIFIED QUALITY MANAGEMENT SYSTEM. PRODUCT IS FOR INVESTIGATIONAL OR RESEARCH USE. NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. 欲获悉更多关于STEMCELL的质控信息,请访问 WWW.STEMCELL.COM/COMPLIANCE.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.